What's the Success Rate of PRP Injections for Joint Pain?

Every week somebody sits down across from me in Southlake, taps a knee or a shoulder, and asks the same thing in slightly different words. Does this actually work?

It's the right question. PRP has been marketed for over a decade, and men in DFW have gotten good at filtering claims. So let's talk about the actual numbers, which come from a genuinely large body of orthopedic and sports medicine research, and then let's talk about what those numbers leave out.

Here's the headline. For knee osteoarthritis, PRP has the strongest evidence of anything we offer in regenerative orthopedics. Reported success rates cluster in the 60 to 80 percent range depending on how you define success. That's a real number, not a marketing number. And the men who land inside that range share a set of features you can check for before you ever book.

What Does the Research Say About PRP Success Rates?

Across randomized trials in knee osteoarthritis, roughly 60 to 80 percent of patients report clinically meaningful pain reduction six months after PRP, and many hold that benefit at twelve months. Tendon indications like tennis elbow and patellar tendinopathy report similar or slightly higher response rates in the published literature.

The knee is where the data runs deepest. Multiple randomized controlled trials over the last decade have compared PRP head to head against hyaluronic acid and against saline placebo. The same pattern keeps showing up: PRP outperforms both, the gap widens at the six and twelve month marks rather than shrinking, and the effect is largest in mild to moderate arthritis where there's still cartilage to work with.

Tendons tell a similar story. Lateral epicondylitis (tennis elbow, though most of my patients got it doing something other than tennis) responds well, with studies reporting 70 to 80 percent of patients meaningfully improved at six months and staying there. Patellar tendinopathy and gluteal tendinopathy have solid supporting data too.

One thing to understand about the word "success" in these studies. It usually means a 30 to 50 percent reduction in pain scores plus a functional gain, not zero pain forever. A man who walks in wanting a nineteen-year-old knee is measuring against the wrong target. A man who wants to hike the Grapevine trails without ibuprofen in his pocket and get back under a barbell is measuring against the right one. That second man is the one who tells me a year later he'd do it again.

Why Do Published Success Rates Vary So Much?

Because PRP is not one product. Platelet concentration, white blood cell content, injection volume, imaging guidance, and the number of sessions vary widely between studies and between clinics. Two men can both say they got PRP and have received biologically different treatments with predictably different outcomes.

This is the part almost nobody explains, and it drives most of the spread you see in the literature.

Platelet concentration changes everything

A basic bedside centrifuge might deliver 2 to 3 times your baseline platelet concentration. A double-spin protocol on a proper system delivers 5 to 7 times. The research increasingly points to a therapeutic threshold somewhere above 5x. Below that, you're injecting something closer to mildly enriched blood. Ask any clinic what concentration factor their system produces. A practice that measures it will tell you the number without hesitating.

Leukocyte content is not a detail

Leukocyte-poor PRP tends to perform better inside a joint capsule, where white cells drive an inflammatory response you don't want near cartilage. Leukocyte-rich PRP has good advocates for tendons, where a controlled inflammatory kick appears to help remodeling. Matching the preparation to the tissue is a small decision that shows up in the outcome months later.

Guidance and dosing

Ultrasound guidance puts the injectate exactly where the pathology lives. Blind shoulder injections have a real miss rate even in experienced hands. And single-session protocols underperform three-session protocols in most knee studies. So ask whether the price includes imaging guidance and how many sessions the protocol calls for. Those two questions sort the field faster than anything else.

If you want the biology underneath all of this, I wrote about how PRP works at the tissue level in an earlier post.

Who Gets the Best Results from PRP Injections?

The strongest responders have mild to moderate joint degeneration with preserved joint space on imaging, a body mass index under roughly 30, no active nicotine use, and one specific structural target rather than diffuse whole-body pain. Metabolically healthy men in their forties and fifties consistently beat the published averages.

Let me describe the man who does spectacularly well here, because if you recognize yourself in this list you should be optimistic.

• Kellgren-Lawrence grade 1 to 3 knee arthritis. There's cartilage remaining and joint space visible on the X-ray. For grade 4 bone-on-bone knees, the better conversation is a staged plan built around delaying or preparing for replacement surgery, and we have real tools for that too.
• A defined structure that hurts. Medial compartment. Patellar tendon. Common extensor origin. Gluteus medius insertion. When we can point at it on ultrasound, we can treat it precisely.
• Reasonable metabolic health. This one surprises people. Platelet function, growth factor signaling, and tissue repair all run downstream of your metabolism. Men with controlled glucose and lower visceral fat heal better, full stop.
• Non-smokers and vape-free. Nicotine constricts the microvasculature that has to deliver the healing response you just invested in.
• Willing to do the rehab. PRP opens a repair window. Loading the tissue correctly during that window is what converts biology into function.

There's a related thread worth pulling. A lot of the men who come to me for knee pain in their forties also turn out to have suboptimal hormones, and testosterone has genuine effects on collagen synthesis, the muscle that supports a joint, and inflammatory tone. I've written about the low testosterone and joint pain connection separately. It's one reason we run labs before we run a needle. When hormones are part of the picture, treating both at once produces a better joint result than treating either alone, and the hormone optimization guide covers what we look at.

How Long Does PRP Take to Work, and How Long Does It Last?

Most men notice little for two to three weeks, feel meaningful change between weeks four and eight, and reach peak benefit around three months. Duration typically runs nine to eighteen months for knee osteoarthritis, and many patients choose an annual maintenance injection rather than waiting for pain to fully return.

PRP is not a cortisone shot, and the timeline is the clearest proof of that. Cortisone quiets pain within 48 hours by suppressing inflammation, then fades, and repeated doses are associated with cartilage loss over time. PRP does close to the opposite. Not much happens early, because you're waiting on a cascade of growth factor release, cell recruitment, and matrix remodeling. Then it builds, and it keeps building past the point where a steroid would have worn off.

Expect a dip in the first 72 hours. The injection provokes a deliberate inflammatory response, so the joint often feels worse before it feels better. That's the treatment doing its job. Skip the anti-inflammatories during that window if you can, since blunting the inflammation blunts the signal you paid for.

On durability, the twelve month data is strong and the eighteen month data is reasonable. Most of my knee patients come back for a single maintenance injection somewhere in the twelve to eighteen month range and stay comfortably ahead of where they started.

Can You Improve Your Own Success Rate?

Yes, and it matters more than most men expect. Correcting vitamin D, addressing iron and anemia, controlling blood sugar, stopping nicotine, sleeping seven hours, and pairing the injection with structured rehab all measurably improve outcomes. The injection is one input into a repair process you largely control.

This is where a physician-run practice separates itself from a walk-in injection shop. Before I inject anybody in our regenerative medicine program, I want a metabolic panel, a vitamin D, a CBC, and a hormone panel. Not to pad the visit. A man with a vitamin D of 18, an A1c of 6.3, and free testosterone in the basement gets a fraction of the benefit that same man gets after eight weeks of correction. Same needle, same platelets, very different biology receiving them.

Adjuncts help as well. Certain peptides support tendon and ligament remodeling, and I'll run them alongside a PRP series for stubborn tendinopathy. If that's new territory, the peptide therapy beginner's guide is a good starting point, and I compared the specific options for connective tissue in this post on peptides for joints and tendons.

For men with more advanced imaging findings, or men who've had a good PRP response and want to push further, the conversation moves toward cell-based options. I broke down the differences in stem cells versus PRP versus exosomes, and hip and labral pathology gets its own protocol discussion.

Who Should Not Receive a PRP Injection?

PRP is not appropriate during active infection, active malignancy, or with platelet function disorders and significant thrombocytopenia. Men on therapeutic anticoagulation need clearance before any hold. Uncontrolled diabetes and active nicotine use should be corrected first, since both suppress the healing response the injection is meant to trigger.

The absolute contraindications are short and real. Active joint or systemic infection is a hard stop. So is active hematologic malignancy or a known platelet function disorder. Men on therapeutic anticoagulation need a conversation with their prescribing physician about whether a brief hold is safe, and when it isn't, we look at other routes.

The relative ones come up far more often and they're fixable. An A1c above 8 means I'd rather spend a few months on your metabolism first, and most men in that situation feel better across the board once we do. Same with nicotine. These aren't reasons to skip PRP. They're reasons to sequence it correctly so the injection lands in a body that can respond to it.

And if the joint pain travels with fatigue, weight you can't shift, and a sense that your engine is running at half power, take a look at low energy in men over 40. Sometimes the joint is the loudest symptom rather than the whole story.

Frequently Asked Questions

Most knee osteoarthritis protocols use three injections spaced two to four weeks apart. Tendon injuries often respond to one or two. We decide after imaging and after seeing your response to the first.

Most plans still classify PRP as investigational and don't reimburse it. We publish transparent cash pricing on our pricing page so there are no surprises at checkout.

For long-term joint health, yes. Cortisone works faster but wears off, and repeated doses can accelerate cartilage loss. PRP works slower and supports repair instead of suppressing it.

The blood draw is routine. The injection feels like pressure and deep ache for about a minute, then soreness for two to three days. We use local anesthetic and ultrasound guidance.

Often yes. Post-meniscectomy and post-arthroscopy knees are common in our practice. Imaging and an exam tell us how much structure remains to work with.

If you've been managing a knee, shoulder, or elbow with ibuprofen and optimism, come talk to me. The first visit is free, we'll look at your imaging and labs together, and I'll show you where you sit on the candidacy list. Book a consultation and we'll get your joint sorted. We see men from Southlake, Grapevine, Keller, and across DFW, and if you're comparing options, our rundown of men's health clinics in Dallas is a fair place to start.